Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC-CLEARLY: Intracoronary Abciximab in STEMI
NCT00894023Phase 3Terminated
- Start
- Jun 2009
- Primary completion
- Dec 2010
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of abciximab in ST elevation myocardial infarction (STEMI). Started Jun 2009; status: terminated.
02
Drugs
abciximab
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00894023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894023.